La nueva terapia celular, al rescate de la reparación de tejidos

by Peaches Biotech

Se destacan algunos párrafos que muestran lo que están en vía de aportar a las terapias celulares y el status de su proyecto PRS ®, biomedicamento inmunomodulador y antiinflamatorio

Read more

L'Hospital Universitari Vall d'Hebron, el primer centro de Cataluña que alcanza cien tratamientos con radiofármacos para pacientes con tumores neuroendocrinos

by Vall d’Hebron

Un 80% de pacientes con tumores neuroendocrinos responden al tratamiento con Lutatera y se ha comprobado que en muchos casos los tumores reducen su tamaño y en otros se estabilizan y mejoran los sín...

Read more

Validan un nuevo equipo para la detección del ganglio centinela en cáncer de próstata

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Han demostrado que gracias a la combinación entre la cirugía robótica y la sonda SENSEI® la técnica del ganglio centinela en cáncer de próstata, que es considerada una técnica compleja, es fia...

Read more

European funding for the treatment of Type 1 diabetes using 3D bioprinting

by IBEC - Institut de Bioenginyeria de Catalunya

IBEC researcher Javier Ramón Azcón has been awarded an “ERC Proof of Concept Grant.” This prestigious funding is granted by the European Research Council to explore the commercial and societal p...

Read more

SparingVision Selects Second Target in Strategic Collaboration with Intellia Therapeutics

by Ysios Capital

SparingVision today announces that it has selected a second target as part of its strategic collaboration with Intellia Therapeutics, Inc.to develop novel genomic medicines utilizing CRISPR-based gene...

Read more

The companies of the BCN Health Booster accelerator raise €51.8 M in the first year of the programme

by Parc Científic de Barcelona

The eleven accelerated companies in the BCN Health Booster raised €16.4 M of private capital, and €35.4 M of public funding during 2022, the first year of the programme’s launch, a period in whi...

Read more

Palex and Inbiomotion introduce pioneering test to aid oncologists in predicting recurrence and survival rates in breast cancer patients

by Ysios Capital

The MAF-TEST® predicts the prognosis of breast cancer patients and helps oncologists to identify those patients who may be able to prevent recurrence and benefit from adjuvant treatment with bisphosp...

Read more

Abyntek Biopharma reaches more than 50 brands in bioreagents distribution

by Abyntek

The basque Biopharmaceutical company is positioned as the main national distributor of bioreagents thanka to its constant expansion of represented brands.

Read more

ADmit therapeutics closes a €5.4 million funding round led by Clave Capital, through its Clave Innohealth f.c.r. fund.

by ADmit Therapeutics

ADmit Therapeutics is a biotechnology company founded at the end of 2017 as a spin-off from the Bellvitge Biomedical Research Institute (IDIBELL). The company is focused on the development and commerc...

Read more

Results on the preclinical efficacy of uric acid in ischaemic stroke published

by Fundació Clínic per a la Recerca Biomèdica

The journal Science Translational Medicine has published the results of a preclinical study carried out on rodents that shows the efficacy of uric acid in improving the prognosis of ischaemic stroke. ...

Read more

AM-Pharma announces positive clinical data from phase 1b study evaluating ilofotase alfa in hypophosphatasia

by Ysios Capital

AM-Pharma B.V. today announced positive clinical results from the Phase 1b study evaluating the company’s proprietary recombinant alkaline phosphatase, ilofotase alfa, as potential enzyme replacemen...

Read more

SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Disease

by Asebio

Spark secures exclusive worldwide rights to SpliceBio’s proprietary Protein Splicing platform to develop, manufacture, and commercialize a gene therapy targeting an undisclosed inherited retinal dis...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Vall d’Hebron leads a European project...

by Vall d’Hebron

The PHOENIX project, involving 13 European institutions, will evaluate...

Photos Stream